MAPT and Alzheimer disease: In this study, except for the markedly decreased amyloid β-42 and increased t-tau and phosphorylated tau (p-tau) in CSF, we discovered significantly decreased levels of thioredoxin-dependent peroxide reductase, mitochondrial (PRDX3) in the CSF of AD subjects, which was consistent with Wang et al. [6].